Lantheus Holdings Completes Asset Acquisition
Ticker: LNTH · Form: 8-K · Filed: Apr 1, 2025 · CIK: 1521036
| Field | Detail |
|---|---|
| Company | Lantheus Holdings, Inc. (LNTH) |
| Form Type | 8-K |
| Filed Date | Apr 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: acquisition, assets, diagnostics
TL;DR
Lantheus Holdings just closed a deal to buy more assets. Big moves in diagnostics!
AI Summary
On April 1, 2025, Lantheus Holdings, Inc. announced the completion of its acquisition of the assets of a company, as detailed in Item 7.01. The filing also includes financial statements and exhibits related to this transaction. Lantheus Holdings, Inc. is incorporated in Delaware and its principal executive offices are located in Bedford, Massachusetts.
Why It Matters
This filing signifies the successful integration of acquired assets, which could impact Lantheus's market position and future revenue streams in the diagnostic substances sector.
Risk Assessment
Risk Level: low — The filing reports on a completed transaction and does not indicate any ongoing risks or uncertainties.
Key Players & Entities
- Lantheus Holdings, Inc. (company) — Registrant
- April 1, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of incorporation
- Bedford, Massachusetts (location) — Principal executive offices
- 331 Treble Cove Road (address) — Business address
- North Billerica (location) — City for business address
- 01862 (zip_code) — Zip code for business address
- 978 671-8001 (phone_number) — Business phone
FAQ
What specific assets did Lantheus Holdings, Inc. acquire?
The filing does not specify the exact assets acquired, only that the 'Completion of Acquisition or Disposition of Assets' is reported under Item 7.01.
What is the financial impact of this acquisition on Lantheus Holdings, Inc.?
The filing mentions 'Financial Statements and Exhibits' but does not provide specific financial details or the impact of the acquisition in this 8-K.
When was the acquisition officially completed?
The earliest event reported is April 1, 2025, which is the date of the report and likely the completion date of the acquisition.
What is Lantheus Holdings, Inc.'s primary business sector?
Lantheus Holdings, Inc. is in the 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES' sector, with SIC code 2835.
Has Lantheus Holdings, Inc. undergone any name changes?
Yes, the company was formerly known as Lantheus MI Holdings, Inc., with a date of name change on May 17, 2011.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 1, 2025 regarding Lantheus Holdings, Inc. (LNTH).